University of Colorado Health Sciences Center, Department of Cell and Developmental Biology, 12635 E. Montview Blvd., Suite 215, Aurora, Colorado 80010
Received 9 December 2004/ Returned for modification 16 January 2005/ Accepted 2 April 2005
(1,3)ß-D-Glucan synthase (EC 2.4.1.34
This article has been cited by other articles:
S produced maximum specific activity in vitro. We tested in vitro C. neoformans (1,3)ß-glucan synthase activity against the (1,3)ß-glucan synthase inhibitors, caspofungin and cilofungin, and have determined that (1,3)ß-glucan synthase activity is very sensitive (apparent Ki of 0.17 ± 0.02 µM and 22 ± 5.7 µM, respectively) to these echinocandins. Taken together with high MICs for C. neoformans (caspofungin MIC, 16 µg/ml; cilofungin MIC, 64 µg/ml), our results indicate that C. neoformans is resistant to caspofungin and cilofungin by a mechanism(s) unrelated to (1,3)ß-glucan synthase resistance.
* Corresponding author. Mailing address: University of Colorado Health Sciences Center, Department of Cell and Developmental Biology, 12635 E. Montview Blvd., Suite 215, Aurora, CO 80010. Phone: (303) 724-3426. Fax: (303) 724-0861. E-mail: Claude.Selitrennikoff{at}uchsc.edu
Antimicrobial Agents and Chemotherapy, July 2005, p. 2851-2856, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.2851-2856.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Clin. Vaccine Immunol.
Clin. Microbiol. Rev.
J. Clin. Microbiol.
ALL ASM JOURNALS
Copyright © 2005 by the American Society for Microbiology. All rights reserved.